logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9340822 B1

PDFFull Text
Date of Patent:
May. 17, 2016

Filed:

Aug. 18, 2014

Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

Applicant:

Biomarin Pharmaceutical Inc., Novato, CA (US);

Inventors:

Brett E. Crawford, Poway, CA (US);

Jillian R. Brown, Poway, CA (US);

Charles A. Glass, Novato, CA (US);

Jim R. Beitel, Novato, CA (US);

Robin M. Jackman, San Diego, CA (US);

Assignee:

BIOMARIN PHARMACEUTICAL INC., Novato, CA (US);

Attorney:

Jones Day

Primary Examiner:

Ralph Gitomer

Int. Cl.
CPC ...
C12Q 1/42 (2006.01); C12Q 1/527 (2006.01); C12Q 1/34 (2006.01); C12Q 1/40 (2006.01); G01N 33/68 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/527 (2013.01); C12Q 1/34 (2013.01); C12Q 1/40 (2013.01); C12Q 1/42 (2013.01); G01N 33/5308 (2013.01); G01N 33/6893 (2013.01); G01N 2333/924 (2013.01); G01N 2400/00 (2013.01); G01N 2800/04 (2013.01); G01N 2800/042 (2013.01); G01N 2800/044 (2013.01); G01N 2800/28 (2013.01); G01N 2800/52 (2013.01);
Abstract

Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.

Find Patent Forward Citations

Crawford, Brett. (2016). Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker (U.S. Patent No. 9340822). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9340822

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…